Suppression of collagen arthritis with antibodies to an arthritogenic, oligoclonal T cell line
- 1 April 1992
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 140 (2) , 444-452
- https://doi.org/10.1016/0008-8749(92)90210-g
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Diversity of rheumatoid synovial tissue T cells by T cell receptor analysis. Oligoclonal expansion in interleukin‐2–responsive cellsArthritis & Rheumatism, 1991
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Monoclonal antibodies and arthritisInflammation Research, 1990
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- An arthritogenic lymphokine in the rat.The Journal of Experimental Medicine, 1985
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985
- Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages.The Journal of Experimental Medicine, 1985
- Antigen-specific suppression of collagen arthritis by adoptive transfer of spleen cellsClinical Immunology and Immunopathology, 1984
- Passive Transfer by Cells of Type II Collagen-Induced Arthritis in RatsJournal of Clinical Investigation, 1978